close icon

Intertek Cannot Assure the Quality of its Stock Returns

Today, we are going to examine the stock of another European company. Intertek is a leading total quality assurance provider. Basically, other companies pay Intertek to test and guarantee the quality of their products and services. The company traces its roots back to 1888 and went public in 2002. It trades on the London Stock Exchange under the ticker ITRK.

The fact that Intertek is over 130 years old is not a coincidence. With the exception of the crisis-hit 2020, the company is profitable, growing and not overburdened with debt. So its fundamentals are not the place to look for cracks in the bullish thesis. At a P/E ratio of 35, the problem is valuation.

Intertek stock weekly Elliott Wave chart

Valuations, however, can remain stretched for quite a while, especially in a zero-rate world. The Elliott Wave chart above, on the other hand, makes things much more specific. It reveals that a clear five-wave impulse has been in progress since 2003. The pattern is labeled (1)-(2)-(3)-(4)-(5) and five sub-waves of (1) and (3) are also visible.

Intertek ‘s Elliott Wave Structure Puts its Valuation into Context

In addition, the guideline of alternation is also on display here. Wave (2) was a sharp decline, while wave (4) looks like an expanding flat correction. Wave ‘c’ of (4) unfolded during this year’s coronavirus selloff. If this count is correct, the post-March surge to a new record must be wave (5).

Unfortunately for the bulls, the theory states that a three-wave correction follows every impulse. The negative phase of the cycle usually erases the entire fifth wave. In Intertek ‘s case, this means a drop to roughly 3800 pence a share can be expected. The bearish RSI divergence between waves (3) and (5) supports the negative outlook. In our opinion, 5760 pence is a risky price to pay for ITRK stock right now.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Undervalued Bristol Myers Stock Can Still Get Cheaper

It’s been almost two years since we shared our bullish stance on Bristol Myers stock. Shares in the pharmaceutical major were changing hands for less than $46 in April, 2019. The company had just announced its planned acquisition of Celgene for about $74 billion and Wall Street apparently didn’t like the risks involved. However, the…

Read More »

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

Lockheed ‘s Correction Still Unfolding as Expected

Almost a year and a half ago, in July 2019, we wrote that Lockheed Martin is likely “setting the stage for an unpleasant surprise.” The stock had just reached a new all-time high and was trading at $370 a share. Optimism was in the air and analysts were more bullish than ever. An indeed, fundamentally,…

Read More »

More analyses